Thyroid cancer
Conditions
Interventions
Experimental group:Oral calcium (600mg/d) and vitamin D3 (alfacalcalcitol 1ug/d) were given for 2 days before surgery
Control group:Placebo
Sponsors
Ruijin Hospital Luwan Branch, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients who aged 20-65 years and diagnosed or suspected thyroid cancer and thyroid surgery was planned.
Exclusion criteria
Exclusion criteria: 1. Parathyroid diseases; 2. Oral calcium or vitamin D3 supplements due to other diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The serum calcium;The serum phosphorus;Parathyroid hormone;Postoperative hospital stay; | — |
Secondary
| Measure | Time frame |
|---|---|
| Drainage;Number of lymph nodes;Parathyroid gland lose;Number of tumors;Number of positive lymph nodes;Maximum tumor diameter; | — |
Countries
China
Contacts
Public ContactJin Xiaoli
Ruijin Hospital Luwan Branch, Shanghai Jiaotong University School of Medicine
Outcome results
None listed